Muraglitazar, a Novel Dual ([alpha]/[gamma]) Peroxisome Proliferator-Activated Receptor Activator, I...
Muraglitazar, a Novel Dual ([alpha]/[gamma]) Peroxisome Proliferator-Activated Receptor Activator, Improves Diabetes and Other Metabolic Abnormalities and Preserves [beta]-Cell Function in db/db Mice
About this item
Full title
Author / Creator
Publisher
New York: American Diabetes Association
Journal title
Language
English
Formats
Publication information
Publisher
New York: American Diabetes Association
Subjects
More information
Scope and Contents
Contents
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor (PPAR) activator, was investigated for its antidiabetic properties and its effects on metabolic abnormalities in genetically obese diabetic db/db mice. In db/db mice and normal mice, muraglitazar treatment modulates the expression of PPAR target genes in white adipo...
Alternative Titles
Full title
Muraglitazar, a Novel Dual ([alpha]/[gamma]) Peroxisome Proliferator-Activated Receptor Activator, Improves Diabetes and Other Metabolic Abnormalities and Preserves [beta]-Cell Function in db/db Mice
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_216488376
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_216488376
Other Identifiers
ISSN
0012-1797
E-ISSN
1939-327X
